COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
doi: https://doi.org/10.1101/2021.03.04.21252540
University of Toronto
Prabhat Jha
University of Toronto
Data Availability
Data available upon request and subject to approval from Unity Health Toronto Ethics Review Board and the Canadian COVID-19 Immunity Task Force.
Posted March 05, 2021.
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
medRxiv 2021.03.04.21252540; doi: https://doi.org/10.1101/2021.03.04.21252540
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (672)
- Anesthesia (181)
- Cardiovascular Medicine (2662)
- Dermatology (224)
- Emergency Medicine (404)
- Epidemiology (12273)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4129)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2672)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3915)
- Nursing (212)
- Nutrition (583)
- Oncology (2056)
- Ophthalmology (590)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1117)
- Primary Care Research (456)
- Public and Global Health (6554)
- Radiology and Imaging (1411)
- Respiratory Medicine (873)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)